Program at a Glance

  • Session times are Korea Standard Time (UTC/GMT+9). Please click the Time Zone Converter button and check your local time.
  • The program is subject to change.
  • If you click the session code, it will lead you to details of the Scientific Programs.
  • We will notify you later about the details of the poster/oral presentation.

SESSION CODE:
[PL] Plenary Lecture, [SS] Scientific Symposium, [JS] Joint Symposium, [ES] Education Session,
[MDCD] Multi-Disciplinary Case Discussion, [OP] Oral Presentation, [LS] Luncheon Symposium, [SL] Satellite Symposium

Sep.3 (WED) Date Sep.4 (THU)
Room D
(Walker Hall 2)
Time Room A
(Vista Hall 1)
Room B
(Vista Hall 3)
Room C
(Walker Hall 1)
Room D
(Walker Hall 2)
Room E
(Grand Hall 4)
08:40-10:10 JS 01
ASCO/KSMO
JS 02
KCSG/KSMO
ES 02 SS 01 SL 01
(8:40-9:20)
janssen
 
SL 02
(9:30-10:10)
Pfizer
10:10-10:20 Break (10 min.)
10:20-10:40 Opening Ceremony
(10:20-10:40)
10:40-11:20 PL 01
11:20-11:30 Break (10 min.)
11:30-12:10 LS 01
MSD
LS 02
Lilly
LS 03
Astrazeneca
LS 04
Daiichi-Sankyo
LS 05
YUHAN
12:10-12:20 Break (10 min.)
12:20-13:50 SS 02 ES 03 SS 03 JS 03
KOSRO/KSMO
SL 03
(12:20-13:00)
MSD
SL 04
(13:10-13:50)
Novartis
13:50-14:00 Break (10 min.)
KSMO Initiatives for Cancer Care Inequity
(14:00-16:00)
14:00-15:30 JS 04
ESMO/KSMO
JS 05
KSSO/KSMO
ES 04 SS 04 SL 05
(14:00-14:40)
Amgen
 
SL 06
(14:50-15:30)
Boryung
15:30-15:40 Break (10 min.)
15:40-16:20 PL 02
Break (10 min.)
ES 01
(16:10-17:30)
16:20-17:50 SS 05 OP 01
16:20-17:20
SS 06 JS 06
KSR/KSMO
SL 07
(16:20-17:00)
IPSEN
Break (10 min.)
Welcome Reception
(17:40~)
SL 08
(17:10-17:50)
JEIL
Date Sep.5 (FRI)
Time Room A
(Vista Hall 1)
Room B
(Vista Hall 3)
Room C
(Walker Hall 1)
Room D
(Walker Hall 2)
Room E
(Grand Hall 4)
08:40-10:10 JS 07
JSMO/KSMO
ES 05 SS 07 JS 08
KSP/KSMO
SL 09
(8:40-9:20)
Takeda
 
SL 10
(9:30-10:10)
Ono
10:10-10:30 Break (20 min.)
10:30-11:10 PL 03  
 
 
11:10-11:30 Break (20 min.)
11:30-12:10 LS 06
Boryung
LS 07
Gilead
LS 08
Astellas
LS 09
Novartis
LS 10
SERVIER
12:10-12:20 Break (10 min.)
12:20-13:50 JS 09
ASCO/KSMO
OP 02
12:20-13:20
MDCD SS 08 SL 11
(12:20-13:00)
innoN
SL 12
(13:10-13:50)
Astellas
13:50-14:00 Break (10 min.)
14:00-14:40 PL 04
|
 
14:40-14:50 Break (10 min.)
14:50-16:20 JS 10
ESMO/KSMO
  SS 09 SS 10 SL 13
(14:50-15:30)
Roche
SL 14
(15:40-16:20)
Merck
16:20-16:40 Closing Ceremony  
 
Date Sep.3 (WED)
Time Room D (Walker Hall 2)
14:00-16:00 KSMO Initiatives for Cancer Care Inequity
16:00-16:10 Break (10 min.)
16:10-17:30 ES 01

Symptom management in advanced cancer: Innovations and best practices
17:30-17:40 Break (10 min.)
17:40~ Welcome Reception
Date Sep.4 (THU)
Time Room A
(Vista Hall 1)
Room B
(Vista Hall 3)
Room C
(Walker Hall 1)
Room D
(Walker Hall 2)
Room E
(Grand Hall 4)
08:40-10:10 JS 01
ASCO/KSMO
JS 02
KCSG/KSMO

Transforming Oncology Research: AI-Powered Clinical Trials
ES 02

Tumor heterogeneity and single-cell analysis

KOR

SS 01

Optimizing the transition to palliative care: Prognostic estimation and communication in oncology
SL 01
(8:40-9:20)
janssen
SL 02
(9:30-10:10)
Pfizer
10:10-10:20 Break (10 min.)
10:20-10:40 Opening Ceremony
(10:20-10:40)
10:40-11:20 PL 01

Breaking new ground: Innovative cancer vaccine therapies
11:20-11:30 Break (10 min.)
11:30-12:10 LS 01
MSD
LS 02
Lilly
LS 03
Astrazeneca
LS 04
Daiichi-Sankyo
LS 05
YUHAN
12:10-12:20 Break (10 min.)
12:20-13:50 SS 02

Revolutionizing GI cancer care with next-generation modalities
ES 03

Cancer survivorship: Shifting paradigms in care

KOR

SS 03

How shall we treat RARE cancer in the era of precision medicine : Progress and challenges ahead
JS 03
KOSRO/KSMO

Optimization of neoadjuvant/adjuvant treatment
SL 03
(12:20-13:00)
MSD
SL 04
(13:10-13:50)
Novartis
13:50-14:00 Break (10 min.)
14:00-15:30 JS 04
ESMO/KSMO

ESMO guideline and the implementation in Asian Pacific Region
JS 05
KSSO/KSMO

Omit surgery in GI cancer treatment
ES 04

Toxicity management in Antibody-Drug Conjugates (ADCs)

KOR

SS 04

Current trends and future perspectives in
GU oncology
SL 05
(14:00-14:40)
Amgen
SL 06
(14:50-15:30)
Boryung
15:30-15:40 Break (10 min.)
15:40-16:20 PL 02

Cancer cachexia: Transition from science to practice
16:20-17:50 SS 05

Current insights and future directions of MBC treatment
OP 01
16:20-17:20
SS 06

Clinical promise of ctDNA-based MRD testing in solid tumors
JS 06
KSR/KSMO

Radiomics revolution: AI and imaging in cancer care
SL 07
(16:20-17:00)
IPSEN
SL 08
(17:10-17:50)
JEIL
Date Sep.5 (FRI)
Time Room A
(Vista Hall 1)
Room B
(Vista Hall 3)
Room C
(Walker Hall 1)
Room D
(Walker Hall 2)
Room E
(Grand Hall 4)
08:40-10:10 JS 07
JSMO/KSMO

The new standard therapy in solid tumors : The combination of immunotherapies
ES 05

Advance of technology - Artificial Intelligence in Oncology

KOR

SS 07

Novel opportunities to target cancer: Emerging strategies in molecular oncology
JS 08
KSP/KSMO

Biomarker for ADC
SL 09
(8:40-9:20)
Takeda
 
SL 10
(9:30-10:10)
Ono
10:10-10:30 Break (20 min.)
10:30-11:10 PL 03

Advances in chemotherapy for gastric cancer- Future perspectives
   
11:10-11:30 Break (20 min.)
11:30-12:10 LS 06
Boryung
LS 07
Gilead
LS 08
Astellas
LS 09
Novartis
LS 10
SERVIER
12:10-12:20 Break (10 min.)
12:20-13:50 JS 09
ASCO/KSMO
OP 02
12:20-13:20
MDCD

Personalized treatment strategies for oligometastatic patients in the new era of cancer therapeutics

KOR

SS 08

Combinatory strategy to enhance immune checkpoint response
SL 11
(12:20-13:00)
innoN
SL 12
(13:10-13:50)
Astellas
13:50-14:00 Break (10 min.)
14:00-14:40 PL 04

Biomarkers to predict efficacy and toxicity of antibody drug conjugates in breast cancer.
 
14:40-14:50 Break (10 min.)
14:50-16:20 JS 10
ESMO/KSMO

How to streamline initiatives for optimising oncology practice
  SS 09

Real-world challenges in GI oncology: Navigating complex treatment decisions
SS 10

Revealing immune response and resistance through spatial
profiling of NSCLC microenvironment
SL 13
(14:50-15:30)
Roche
SL 14
(15:40-16:20)
Merck
16:20-16:40 Closing Ceremony